Company: MDCXW
Filing Date: 2025-05-28
Form Type: CORRESP
Source: 0001062993-25-010432
Chunk: 0

Company: Medicus Pharma Ltd.
Filing Date: 2025-05-28
Form: CORRESP
Chunk 0
---
<div align='center'>Medicus Pharma Ltd.
300 Conshohocken State Road, Suite 200
Conshohocken, PA 19428</div>

May 28, 2025

Division of Corporation Finance

Office of Life Sciences

Securities and Exchange Commission
100 F Street, N.E.
Washington, D.C. 20549

Attention: Joshua Gorsky

Re: Medicus Pharma Ltd.
Registration Statement on Form S-1
Filed May 27, 2025
CIK: CIK0001997296

Dear Ladies and Gentlemen:

Pursuant to Rule 461 of the Securities Act of 1933, as amended, we hereby request that the effective date of the Registration Statement on Form S-1, File No. 333-287599, as amended (the ""), relating to the registration of 1,375,000 units, each unit consisting of one common share of Medicus Pharma Ltd. (the "Company"), no par value, and one warrant to purchase one common share, be accelerated to May 29, 2025 at 5:00 PM ET or as soon thereafter as may be practicable.

Please contact Christopher J. Cummings of Paul, Weiss, Rifkind, Wharton & Garrison LLP, special counsel to the Company, at (212) 373-3434, as soon as the Registration Statement has been declared effective, or if you have any other questions or concerns regarding this matter.

<div align='center'>*****</div>

| Very truly yours, |                                                |
| By:               | /s/ Raza Bokhari                               |
| Name:             | Dr. Raza Bokhari                               |
| Title:            | Executive Chairman and Chief Executive Officer |